SecBot SecBot
3 ·Filed Oct 23, 2026

HELP

Helus Pharma Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 3h ago SEC0000912282-26-001383
Form 3 — initial insider ownership statement
Actionable Insight • Neutral

Routine initial filing — no trading signal. Monitor for any subsequent open-market purchases or sales by Hoskins that could indicate conviction.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Eric Hoskins filed a Form 3 initial statement of beneficial ownership, disclosing 156,000 common shares held by Lucky Square Holdings Inc., 1,316 shares held directly, 1,316 shares held by spouse, and 30263 warrants exercisable at $6.79. This is a routine insider filing with no material new information.

Key Facts

  • Eric Hoskins filed Form 3 as a new reporting person for Helus Pharma Inc.
  • Beneficial ownership includes 156,000 common shares held by Lucky Square Holdings Inc.
  • Direct holdings: 1,316 common shares.
  • Spousal holdings: 1,316 common shares.
  • Warrants: 30,263 exercisable at $6.79, expiring 2030-11-15, held by Lucky Square Holdings Inc.
  • Warrant exercise price converted from C$9.50 at C$1.4 = US$1.00.

Financial Impact

No financial impact — initial ownership disclosure only.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0000912282-26-001383
Document: 0000912282-26-001383-index.html0000912282-26-001383
Document: 0000912282-26-001383.txt0000912282-26-001383
36 reports for HELP
Performance horizon
50% Hit rate @ T+20 2 of 4 directional calls Went positive at some point 2 of 4 best @ T+20▲ +45.91%Aug 3, 2026
Filters
Rows
Reports for HELP — sortable, filterable
TypeNow
Oct 26, 2026
today
3
NEUTRAL ★ 2/10
$10.11awaiting T+20—$10.36 (+2.47%)
Oct 26, 2026
today
3
NEUTRAL ★ 2/10
$10.86awaiting T+20—$10.36 (−4.56%)
Oct 23, 2026
3d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 23, 2026
3d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 23, 2026
3d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 23, 2026
3d ago
3
NEUTRAL ★ 2/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 21, 2026
5d ago
6-K
NEUTRAL ★ 5/10
$10.50awaiting T+20—$10.36 (−1.33%)
Oct 15, 2026
11d ago
6-K
NEUTRAL ★ 3/10
$11.05awaiting T+20—$10.36 (−6.24%)
Oct 15, 2026
11d ago
Press Release
NEUTRAL ★ 3/10
$11.05awaiting T+20—$10.36 (−6.24%)
Oct 8, 2026
18d ago
6-K
NEUTRAL ★ 4/10
$10.72awaiting T+20—$10.36 (−3.36%)
Showing 10 of 36

US Market Status

Market Closed — Opens Wed (10h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 23, 2026